BiondVax Pharmaceuticals Ltd.
5 SlideShares
Personal Information
Secteur d’activité
Medical / Health Care / Pharmaceuticals
Site Web
www.biondvax.com
À propos
BiondVax (NASDAQ: BVXV) is a biopharmaceutical company developing a universal flu vaccine, designed to provide multi-season and multi-strain protection against most human influenza virus strains, including both seasonal and pandemic flu strains. BiondVax’s technology utilizes a unique, proprietary combination of conserved and common peptides from influenza virus proteins to activate both arms of the immune system for a cross-protecting and long-lasting effect.
Coordonnées
Mots-clés
flu biondvax universal flu vaccine influenza pandemic bvxv seasonal flu flu vaccine h7n7 h5n1 h3n2 h1n1 clinical trials nasdaq pharma h7 h5 biotech vaccine living well magazine pandemic flu
Tout plus

Présentations

(2)

BiondVax 8 page brochure

il y a 7 ans • 542 Vues

BiondVax presentation q4 2017

il y a 6 ans • 529 Vues

Documents

(3)

Is flu prevention possible? [Living Well Magazine March/April 2016]

il y a 8 ans • 385 Vues

BiondVax - AGM Notice + Proxy Statement 2022.pdf

il y a 2 ans • 305 Vues

BiondVax Pharmaceuticals Ltd - Proxy Statement - EGM 13Dec2022

il y a 1 an • 111 Vues
Personal Information
Secteur d’activité
Medical / Health Care / Pharmaceuticals
Site Web
www.biondvax.com
À propos
BiondVax (NASDAQ: BVXV) is a biopharmaceutical company developing a universal flu vaccine, designed to provide multi-season and multi-strain protection against most human influenza virus strains, including both seasonal and pandemic flu strains. BiondVax’s technology utilizes a unique, proprietary combination of conserved and common peptides from influenza virus proteins to activate both arms of the immune system for a cross-protecting and long-lasting effect.
Mots-clés
flu biondvax universal flu vaccine influenza pandemic bvxv seasonal flu flu vaccine h7n7 h5n1 h3n2 h1n1 clinical trials nasdaq pharma h7 h5 biotech vaccine living well magazine pandemic flu
Tout plus